期刊文献+

^(99m)Tc-MAAG_2肿瘤显像剂的合成及生物分布研究 被引量:3

SYNTHESIS AND BIODISTRIBUTION OF ^(99m)Tc-MAAG_2 AS TUMOR IMAGING AGENT
在线阅读 下载PDF
导出
摘要 合成并表征了新的小肽配体N -(S- 三苯甲基巯基乙酰基)丙氨酰甘氨酰甘氨酸(Tr- MAAG2 ).通过直接标记法制备了水溶性配合物99mTc -MAAG2,并对其体外稳定性进行了检测.研究了配合物99mTc- MAAG2 在荷瘤鼠体内的生物分布以及血液清除,结果表明,99mTc- MAAG2 在肿瘤和肌肉中的质量摄取率am之比为2. 67,肿瘤和血液的am之比为0.75,血液清除较快. A new peptide ligand N-(S-tritylmercaptoacetyl)alanylglycylglycine (Tr-MAAG 2) is synthesized and characterized by IR, 1 HNMR, 13 CNMR and elemental analysis. The complex 99m Tc-MAAG 2 is prepared by directly labeling method. The partition coefficient and stability in vitro indicate that the complex is hydrophilic and stable over a period of 6 h at room temperature. The biodistribution of 99m Tc-MAAG 2 in mice bearing S180 tumor shows that the uptake ratios of tumor-to-muscle and blood at 3 hours post injection are 2.67 and 0.75, respectively, and quick blood clearance.
出处 《北京师范大学学报(自然科学版)》 CAS CSCD 北大核心 2005年第2期166-168,共3页 Journal of Beijing Normal University(Natural Science)
基金 国家自然科学基金资助项目(20171008 20371009) 北京师范大学青年科学基金(理科)资助项目(107197)
关键词 肿瘤显像剂 肽配体 N-(S-三苯甲基巯基乙酰基)丙氨酰甘氨酰甘氨酸 ^99mTc-MAAG2 生物分布 tumor imaging agent peptide ligand Tr-MAAG_2 ^(99m)Tc-MAAG_2 biodistribution
  • 相关文献

参考文献9

  • 1张华北,李波,齐传民,谢懿,郭雪峰,戴梅,刘伯里.^(99)Tc^m-膦混配配合物的制备和生物分布[J].核化学与放射化学,2002,24(2):84-90. 被引量:6
  • 2Weiner R E, Thakur M L. Radiolabeled peptides in the diagnosis and therapy of oncological diseases [J]. Appl Radiat Isot, 2002, 57:749
  • 3Chen X Y, Park R, Shahinian A H, et al. 18 F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis [J]. Nucl Med Biol, 2004, 31:179
  • 4Mcafee J G, Neumann R D. Radiolabeled peptides and other ligands for receptors overexpressed in tumor cells for imaging neoplasms [J]. 1996, 23: 673
  • 5Liu S, Edwards S D. 99m Tc-labeled small peptides as diagnostic radiopharmaceuticals [J]. Chem Rev, 1999,99: 2235
  • 6Okarvi S M. Recent development in 99mTc-labeled peptide based radiopharmaceuticals: an overview [J]. Nucl Med Comm, 1999, 20:1093
  • 7Behr T M. Imaging tumors with peptide-based radioligands [J]. Quart J Nucl Med, 2001, 45(2): 189
  • 8Schneider R F, Subramanian G, Feld T A, et al. N, N'-bis ( S-benzoylmercaptiaetamido ) ethylenediamine and propylenediamine ligands as renal function imaging agents [J]. J Nucl Med, 1984, 25:223
  • 9Ilgan S, David J, Yang P D, et al. Imaging tumor folate receptor using 111In- DTPA-methotrexate [J]. Cancer Biotherapy Radiophamaceuticals, 1998, 13: 427

二级参考文献7

  • 1VANDERHEYDEN J L,KARREN L,DENNIS LN,et al.Preparation and Characterization of [99mTc(DMPE)2 X2 ] (DMPE= 1, 2-bis(dimethylphosphino)ethane)[].International Journal of Applied Radiation and Isotopes.1983
  • 2ILGAN S,DAVID J,YANG,P D,et al.Imaging Tumor Folate Receptrs Using 111 In-DTPAMethotrexate[].Cancer Biotherapy.1998
  • 3GERSON MC,MILLAND RW,MAGORON AJ,et al.Myocardial Uptake and Kinetic Properties of Technetium-99m-Q3 in Dogs[].The Journal of Nuclear Medicine.1994
  • 4Vavourki H,Papadopoulos M,Mastrostamatis S,et al.Preparation and Bio-distribution of Cationic Complex[TcⅢ (sacac)2 (PPh)3 ]+[].The Journal of Nuclear Medicine.1992
  • 5DODONOV J,MEDOS H.Preparation of Tetraphynylphonium Salts[]..1928
  • 6SCHNEIDER R F,SUBRAMANIAN G,FELD T A,et al.N, N′-bis(S-Benzoylmercaptoacet Amido)Ethylenediamine and Propylenediamine Ligands as Renal Function Imaging Agents[].The Journal of Nuclear Medicine.1984
  • 7DEUTSCH E,VANDERHEYDEN JL,GERUNDINI P,et al.Development of Nonreducible Technetium99m ( Ⅲ) Cations as Myocardial Perfusion Imaging Agents: Initial Experimence in Humans[].The Journal of Nuclear Medicine.1987

共引文献5

同被引文献58

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部